Patent ID: 7981895

Claim:
A method for the treatment of a condition selected from melanoma or leukemia or cervical cancer comprising administering a therapeutically-effective amount of a compound of the following formula or a pharmaceutically acceptable salt thereof: wherein: the piperazin-1,4-diyl group is optionally substituted at one or more the 2-, 3-, 5-, and 6-positions with C 1-4 alkyl; Q 1 is a covalent bond; saturated C 1-3 alkylene optionally substituted with -Ph; partially unsaturated C 2-3 alkylene; or —O—C 1-3 alkylene; either: J 1 is a covalent bond or —C(═O)— and J 2 is —C(═O)—; or: J 1 is a covalent bond and J 2 is —S(═O) 2 —; Q 2 is —(CH 2 ) 5 —, —(CH 2 ) 8-3 —(CH 2 ) 7-3 —(CH 2 ) 8 —, or phenylene-ethenylene; Cy is phenyl, pyridinyl, furanyl, indolyl, pyrrolyl, imidazolyl, pyrazinyl, pyridizinyl, naphthyl, quinolinyl, indolyl, benzimidazolyl, benzothiofuranyl, fluorenyl, acridinyl, or carbazolyl; and is optionally substituted.